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Comparison of Isoflurane and Midazolam as Hypnotic Supplementation to 
Moderately High-Dose Fentanyl During Coronary Artery Bypass Grafting: 
Effects on Systemic Hemodynamics and Early Postoperative Recovery Profile
Jacques J. Driessen, MD, and Marianne Giart, MD
Objective: The aim of this study was to compare isoflu­
rane and midazolam as hypnotic adjuncts to moderately 
high-dose fentanyl during coronary artery bypass grafting 
(CÀBG) with regard to perioperative hemodynamics and 
early postoperative recovery profile.
Design: Prospective open randomized clinical trial.
Setting: Single university-affiliated medical center.
Participants: Thirty patients scheduled for elective pri­
mary CABG were randomly divided into two groups 
receiving either isoflurane or midazolam as adjuncts to 50 
lJig/kg of fentanyl.
intervention: Anesthesia was induced with intravenous 
fentanyl, 10 |j,g/kg, and midazolam, 0.1 mg/kg, and main­
tained with either isoflurane, 0.6%, or midazolam, 0.1 mg/kg/ 
hour, in intravenous infusion. Before the sternotomy, all 
patients received 30 |xg/kg of fentanyl. Midazolam and 
isoflurane were stopped at the start of cardiopulmonary 
bypass (CPB), At rewarming, all patients received fentanyl, 5 
to 10 |xg/kg, and either isoflurane, 0.6%, or midazolam, at a 
reduced rate of 0.05 mg/kg/h. Changes in systolic blood 
pressure of more than 20% from baseline were first treated 
with vasoactive drugs. Hypertension was corrected with
ketanserin, 10 to 20 mg; hypotension with ephedrine, 5 mg.
« i
For a mean blood pressure of less than 50 mmHg during CPB 
phenylephrine, 0.25 to 0.5 mg, was administered. When 
hypotension persisted despite a vasopressor, the administra­
tion of midazolam or isoflurane was stopped. Postopera- 
tively, the patients were mechanically ventilated overnight 
and sedated with intermittent doses of fentanyl, 0.15 mg, 
and midazolam, 5 mg.
Measurements and Main Results: Routine five-lead electro­
cardiogram (ECG) and invasive hemodynamic monitoring 
using a pulmonary artery catheter were performed. The 
mean dose of fentanyl was 3.9 mg in the midazolam group
P URE HIGH-DOSE OPIOID (sufentanil or fentanyl) anes­
thesia is widely used for adult heart surgery because of its 
excellent hemodynamic stability in patients with limited cardiac 
reserve, but is often unable to sufficiently suppress the hyperdy­
namic hemodynamic responses to strong surgical stimuli.1*2 
Furthermore, the duration of postoperative recovery and respira­
tory support is frequently prolonged, and awareness is not 
always prevented.3,4
The most commonly used drugs to supplement opioids for 
anesthesia during cardiac surgery are the volatile anesthetics 
and intravenous hypnotic-anesthetics. From the latter, the 
benzodiazepines, particularly midazolam, are popular because 
of their mild hemodynamic effects.5 Few, if any, studies have 
compared the effects on systemic hemodynamics and the 
recovery characteristics associated with inhalation versus benzo-
From the Department o f Anesthesiology and Intensive Care, St Jan 's 
Hospital\ Rudders hove JO, 8000 Brugge, Belgium.
Address reprint requests to Jacques J. Driessen, MD, Department of 
Anesthesiology, University Hospital Nijmegen, Geert Grooteplein, 10, 
6500 HB Nijmegen, The Netherlands.
Copyright © 1997 by W.B. Saunders Company 
1053-0770/97/1106-0011$3.00/0
versus 3.6 mg in the isoflurane group. There were no 
significant perioperative differences between groups in 
cardiac output, filling, or pulmonary artery pressures. Systolic 
blood pressure from the initial incision to CPB was lower in 
the isoflurane group compared with the midazolam group. 
During this interval, ketanserin was required in nine patients 
from the midazolam group at a mean dose of 26 mg, 
compared with only one patient in the isoflurane group. 
During and after CPB, there was no difference in ketanserin 
and in vasopressive/inotropic agent requirements. Tempo­
rary cessation of midazolam was required in four patients, 
for a mean of 34 minutes; whereas isoflurane was stopped in 
10 patients for 36 minutes, mostly in the post-CPB period. 
Time to awakening and to extubation in the midazolam 
group (217 minutes and 19.5 hours) and the isoflurane group 
(193 minutes and 18.2 hours) were comparable. Between 
intensive care unit (ICU) admission and extubation, the 
patients in the midazolam group received 0.89 mg of 
fentanyl and 36.5 mg of midazolam compared with 0.98 mg 
of fentanyl and 36.2 mg of midazolam in the isoflurane 
group. There was a tendency for a higher postoperative 
pulmonary shunt and more severely impaired oxygenation 
in the isoflurane group.
Conclusion: Midazolam supplementation to fentanyl re­
quired more frequent antihypertensive escape during the 
pre-CPB period than isoflurane. However, more frequent 
cessation of isoflurane caused by hypotension was needed 
in the post-CPB period. No difference in awakening and ICU 
discharge was found.
Copyright © 1997 by W.B. Saunders Company
»
KEY WORDS: midazolam, isoflurane, coronary bypass sur- 
geryf maintenance of anesthesia
diazepine supplementation to an opioid-based anesthesia tech­
nique.
The aim of the current study in 30 patients was a prospective 
and randomized comparison between isoflurane (ISO) and 
midazolam (MID) as hypnotic adjuncts to moderately high-dose 
fentanyl/oxygen in air anesthesia during coronary artery bypass 
grafting (CABG) with regard to perioperative hemodynamics 
and early postoperative recovery profile.
METHODS
Thirty patients scheduled for elective primary CABG were included. 
Patients were excluded if they were older than 70 years, had diabetes 
type I, uncontrolled arterial hypertension, preoperative ventricular 
dysfunction (radionuclide ejection fraction < 3 5 % or left ventricular 
end-diastolic pressure > 2 0  mmHg), myocardial infarction within I 
month before surgery, morbid obesity (Quetelet index >30), obstructive 
lung disease (forced expiratory volume in I second [FEV|] or forced 
vital capacity [FVC] <70%  of predicted), and with more than five 
anticipated bypasses. After the preoperative visit, the investigators 
controlled the eligibility and assigned the patients to one of the two 
treatment groups according to a randomization list. The study was 
approved by the local Ethical Committee, and informed consent from 
the patients was obtained.
The patients continued their preoperative cardiac medication up to
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the night before surgery. They were premedicated with diazepam, 10 
mg, orally on the evening before surgery, and with diazepam, 10 mg, 
orally and fentanyl, 0.05 mg, and droperidoi, 2.5 mg, intramuscularly, 1 
hour before surgery.
Anesthesia was induced in all patients with slow intravenous (IV) 
injection of fentanyl, 10 jug/kg, followed by midazolam, 0 .! mg/kg, and 
pancuronium, 0.1 mg/kg. After oral endotracheal intubation, ventilation 
was controlled using the AV1 anesthesia respirator (Driigerwerk AG, 
Liibeck, Germany) with a fresh gas flow of 4 liters, consisting of 50% 
oxygen in air. Minute volume ventilation was adjusted to achieve an 
end-tidal CO2 of 30 to 34 mmHg. After endotracheal intubation, 
anesthesia was maintained with either ISO, 0.6%, using a Vapor 19.3 
vaporizer (Driigerwerk AG, Lübeck, Germany) or MID, 0.1 mg/kg/h, by 
continuous IV infusion using a syringe pump. End-tidal ISO was 
analyzed with a Marquette analyzer. Five minutes before sternotomy, 
fentanyl, 30 pg/kg, was given intervenously (IV) over 5 minutes in 
divided bolus doses in both groups. Pancuronium, 4 mg IV, was given 
before the onset of cardiopulmonary bypass (CPB). Administration of
*
MID or ISO was stopped at the onset of CPB. At rewarming, either an 
MID infusion, at a reduced rate of 0.05 mg/kg/h, or isofiurane, 0.6%, 
delivered to the oxygenatorduring CPB, was restarted. Fentanyl, 5 to 10 
jig/kg IV, was given to all patients at the start of rewarming. Both MID 
and ISO were continued until closure of the skin. During the pre-CPB 
period, lactated Ringer’s solution and modified gelatin solution (Gelo-
►
plasma, Jnstitut Mérieux, Benelux) were infused at 100 to 200 mL/h to 
obtain optimal central venous pressures.
CPB was performed using a nonpulsatile roller pump and a mem­
brane oxygenator. At 10 minutes before CPB, methylprednisolone (2 g), 
heparin (3 mg/kg), and furosemide (20 mg) were administered intrave­
nously. A balanced prime (1,500 mL of modified gelatin substitute, 
Geloplasma, 100 mL of mannitol 20%, 50 mEq of sodium bicarbonate, 
250 mL of human albumin 20%, and 50 mg of heparin) was used. 
Venous reservoir, cardiotomy reservoir, hollow-fiber membrane oxygen­
ator, arterial line filter, and tubings were similar in both groups, On-line 
monitoring of pH, carbon dioxide partial pressure (PCO2), partial 
pressure of oxygen, and oxygen saturation (SO2) for both arterial and 
venous blood was done using CDI 300 (CDI Inc/3M, Tustin, CA). 
Myocardial protection during aortic cross-clamping was achieved with 
cold Bleese cardioplegic solution and with topical ice on the myocar­
dium. During aortic cross-clamping, the lungs were not ventilated. The 
pump flow was reduced to 1.7 L/min/m2 during hypothermia (nasopha­
ryngeal temperature 25 to 28°C), and raised to 2.5 L/min/m2 during 
rewarming. During hypothermic CPB, et-stat management of acid-base 
balance was used by varying the fresh gas flow to the membrane 
oxygenator to obtain a temperature-uncorrected arterial PCO2 of about 
40 mmHg.
After weaning from CPB and establishment of an adequate circula­
tion, protamine sulfate, 3 mg/kg, was given to neutralize the heparin. 
Blood transfusion and infusions of crystalloids or colloids were given 
for optimal filling and a post-CPB hematocrit of 25% to 30%.
Postoperatively, in the intensive care unit (ICU), the patients were 
mechanically ventilated (Servo ventilator 900 C, Siemens-Elema, 
Germany) with a fractional inspired oxygen (F1O2) of 0 4  to 0.6 and 
with 5 cml-^O positive end-expiratory pressure for patients with 
internal mammary bypasses. The ICU nurses evaluated the patients’ 
level of sedation every 30 minutes and recorded the time at which the 
patients first opened their eyes and responded to a verbal command. For 
subsequent analgesia and sedation, fentanyl, 0.15 mg, and MID, 5 mg, 
were given IV when necessary, but not before awakening. Weaning 
from artificial ventilation was performed on the first postoperative day, 
and patients were extubated when pH remained 7.35 or above and 
arterial oxygen pressure (Pa0 2 ) greater than 100 mmHg with an F 1O2 of 
less than 0.6 during 1 hour on continuous positive airway pressure, All 
patients remained in the ICU for at least 2 nights regardless of their 
clinical status.
Routine clinical monitoring using a 5 -lead electrocardiogram and a 
radial artery invasive blood pressure was started before induction of 
anesthesia. Standard leads II and modified V5 were continuously 
monitored and used for ST segment analysis to detect myocardial 
ischemia (Marquette Electronics Inc series 7010 recorder, Milwaukee, 
WI). Myocardial ischemia was defined as new down sloping or 
horizontal ST-segment depression of more than I mm or ST elevation o f 
more than 2 mm, measured 60 ms from the J-point and lasting at least 2 
minutes. A thermodilution pulmonary artery catheter, placed through 
the right internal jugular vein after induction of anesthesia, was used for 
measurement of cardiac output (CO), central venous pressure (CVP), 
mean pulmonary artery pressure, and pulmonary artery capillary wedge 
pressure. CO was determined using the thermodilution method, and 
triplicate values (of measurements with intermeasurement variability of 
<10%) were averaged. During CPB, the pump flow rate was used for 
CO and CVP was determined as 0. Hemodynamic and pulmonary 
calculations (systemic vascular resistance, pulmonary vascular resis­
tance, and pulmonary shunt [Qs/Qt]) were derived from standard 
formulae in the Marquette 7010 monitor. Measurements were made 
before the skin incision (Tj), during CPB 10 minutes after aortic 
cross-clamping (T2), during CPB 10 minutes after release o f the aortic 
cross-clamp (T3), 10 minutes after the end of CPB (T4), and I hour after 
admission to the ICU (T5). Arterial and mixed venous (or venous during 
CPB) blood gas analysis was performed using an automatic blood gas 
analyzer (ABL 4 Acid-base Laboratory, Radiometer, Copenhagen, 
Denmark).
The primary objective for all patients was an arterial pressure within 
20% of baseline values. Hemodynamic deviations were primarily 
adjusted by specific escape vasoactive drugs. Hypertension was treated 
with ketanserin in divided 10-mg doses. Ketanserin is a 5 -HT2 receptor 
blocker with central ai-adrenoceptor blocking properties. It is suitable 
to prevent and treat hypertension during and after CABG .6 Hypotension 
before or after CPB was treated with ephedrine, 5 mg in bolus doses. 
Hypotension during CPB (MAP <50 mmHg with normal flow) was 
treated with phenylephrine, 0.25 to 0.5 mg bolus doses. When 
hypotension persisted despite vasopressor therapy, the administration of 
MID or ISO was stopped. Tachycardia was treated with metoprolol, 2.5 
to 5 mg IV. Bradycardia associated with hypotension was treated with
*
ephedrine or with external atrial or ventricular pacing at the end of CPB. 
Persistent low cardiac output was treated with filling adjustment and 
dopamine infusion.
The main data are presented as mean and SD. Statistical comparisons 
within and between the two groups were done using paired and unpaired 
Student’s /-test for continuous data with normal distribution. Compari­
sons of blood pressure at different times between groups were per­
formed using the area under the curve method. When distribution was 
not normal, the Wilcoxon rank-sum test or the Mann-Whitney U-test 
was performed. The chi-square test was used for ordinal patient data. A 
p value of <0.05 was considered significant.
RESULTS
There were no significant differences in the general character­
istics of the patients and the surgical data (Table 1).
The total peri operatively administered dose of fentanyl was 
3.9 mg (SD -  0.7) in the MID group versus 3.6 mg (SD ~ 0.8) 
in the ISO group. The maintenance dose of MID was 23.9 mg 
(SD = 5.3) during 218 minutes (SD — 42) of administration. 
The calculated dose of liquid isofiurane consumed during a 
mean of 187 minutes (SD = 48) of administration was 22,7 mL 
(SD = 6.2).
During surgery, there were few statistically significant differ­
ences in systemic hemodynamics between both groups (Table
2). Mean arterial pressure before incision (Ti), which occurred
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Table 1. Demographics and Other Patient Characteristics
Group MID Group ISO
No. of patients 15 15
Age (yr) 61 (4) 63 (7)
Weight (kg) 78(14) 77(14)
Height (cm) 172(10) 170 (8)
Cardiac medication
ß-blockers 11/15 11/15
Nitrates 8/15 10/15
Calcium channel blockers 3/15 6/15
Molsidomin 5/15 5/15
Previous Ml 10/15 9/15
NYHA class
l-ll 10/15 9/15
)
III 5/15 6/15
CPB time (min) 131 (39) 132 (48)
Ischemic time (min) 70 (29) 69 (30)f
Duration of anesthesia (min) 369 (55) 366 (59)
Cardioplegia (mL) 984 (316) 1,039 (426)
►
No. of grafts 3.3 (1.1) 3.4 (1.2)
NOTE. Values represent mean (SD of mean between brackets) or 
number of patients.
Abbreviations: Ml, myocardial infarction; CPB, cardiopulmonary 
bypass, NYHA, New York Heart Association.
about 15 to 30 minutes after the start of the maintenance 
anesthetic, was lower in the ISO group, and heart rate after 
weaning from CPB (T4) was significantly higher in the MID 
group.
Figure 1 shows the course of systolic arterial pressure (SAP) 
during surgery and early ICU admission. SAP in the pre-CPB 
period was comparable before the start of either ISO or MID, 
but thereafter was lower in the ISO group during the whole 
pre-CPB period. In the post-CPB period, there were no signifi­
cant differences in SAP between the groups, although SAP
STERN 5'
< ' t 
Fig 1. Pre- and post-CPB changes in systolic arteriai pressure 
(SAP). Data are mean and 1 SD. IND, induction of anesthesia; ETT,■ n
endotracheal intubation; INC, incision; STERN, sternotomy; HEP, 
heparin; OR, operating room. *p <  0.05 for differences between the 
two groups.
4 t
Table 2. Hemodynamics Before, During, and After CPB
Group Tt . t 2 ,t3 t 4 t 5
Q (L/min/m2) MID 2.4 (0.5) 2.0 (0.2) 2.3 (0.2) 3.9 (1.0) 3.0 (0.8)
ISO 2.2 (0.3) 1.9 (0.2) 2.4(0.1) 3.6 (0.5) 3.1 (0.5)
HR (beats/min) MID 61 (11) --- --- 86 (8)* 77 (10)
ISO 64(18) --- --- 78 (12)* 74(15)
MAP (mmHg) MID 76(11)*» 71 (11) 66 (14) 60 (9) 78(16)
ISO 64 (9)* 64(11) 71 (13) 60 (8) 79 (12)
MPAP (mmHg) MID 14(4)s --- --- 20 (5) 19(4)
ISO 15(5) --- --- 19(4) 20 (4)
PCWP (mmHg) MID 7(3) --- -- , 8 (2) 8(4)
ISO 7(3) --- --- 7(3) 9(3)
CVP (mmHg) MID 6 (2) -- --- 8(3) 8(4)
ISO 6 (2) --- --- 8(3) 1 8(3)
SVR (dyne • s • cm-5) MID 1,306 (340)» 1,411 (237) 1,186 (253)4 618 (185) 1,123 (390)
ISO 1,168 (362) 1,202 (200) 1,234 (200) 630 (148) 1,207 (247)
PVR (dyne • s • cm 5) MID 140 (59) --- — 160 (97) 168 (79)
ISO 172 (74) --- — 138 (48) 153 (53)
NOTE. Data represent mean and SD (between parentheses).
Abbreviations: Q, cardiac index or pump flow per m2; MAP, mean arterial pressure; MPAP, mean pulmonary artery pressure; T), before skin 
incision; T2, 10 minutes after aortic cross-clamping; T3, 10 minutes after release of the aortic cross-clamp; T4, 10 min after the end of CPB; T5, 1 hour 
after ICU admission; HR, heart rate; PCWP, pulmonary capillary wedge pressure; CVP, central venous pressure; SVR, systemic vascular resistence; 
PVR, pulmonary vascular resistence.
*p  < 0.05.
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Table 3. Pharmacologic intervention With Vasoactive Drugs 
and Frequency of the Need for Temporary Cessation of Hypnotic
Supplementation
Group MID Group ISO
Pre-CPB
Ketanserin 9 (24 mg, SD = 12) 1 (10 mg)*
Ephedrine 0 0
During CPB
Ketanserin 9 (26 mg, SD = 12) 8 (19 mg, SD -  11)
Phenylephrine 3 4
Post-CPB in OR
Ketanserin 0 0
Ephedrine 7 (9 mg, SD = 6) 11 (8 mg, SD = 3)
Dopamine 2 1
Cessation of hypnotic
supplementation 4 (34 min, SD = 13) 10(36 min, SD = 24)*
NOTE. Values represent number of patients. Values between brack­
ets represent mean and SD.
*p <  0.05 for differences between ISO and MID groups.
tended to be lower in the ISO group at sternal closure and end of 
surgery.
The need for vasoconstrictor/inotropic or hypotensive sup­
port in each of the two groups is given in Table 3. During the 
incision-CPB interval, ketanserin was required more frequently 
and in higher dosage in patients from the MID group than in the 
ISO group (p <  0.05). During CPB, there was no statistically 
significant difference in ketanserin or phenylephrine require­
ments. No patient in either group received ketanserin in the 
post-CPB period. All patients were successfully weaned from 
CPB at the first attempt, and temporary inotropic support with 
dopamine was required in two MID patients compared with one 
patient in the ISO group. In the post-CPB period, there was no 
significant difference in the incidence and dose of ephedrine 
requirements. Inotropic support in the ICU was necessary in one 
patient from the MID group and two ISO patients. There were 
no statistically significant differences in the postoperative 
requirements for hypotensive agents in the ICU. There was a 
statistically higher incidence in the need to discontinue the
hypnotic supplement because of persistant hypotension (Table
3). Temporary cessation of MID was required in four patients 
for a mean of 34 minutes (SD = 13), whereas ISO had to be 
discontinued in 10 patients for 36 minutes (SD = 24), mostly in 
the post-CPB period.
Evidence of transient myocardial ischemia from ST-segment 
analysis in the pre-CPB period occurred in one patient in the 
MID group compared with two in the ISO group. Postoperative 
creatine kinase MB isoenzyme activity on the first postoperative 
day was 21.1 U/L (SD = 14.4) in the ISO group and 22.1 U/L 
(SD = 21.6) in the MID group.
Table 4 shows the oxygenation and blood gas values at time 
points T|, T3, T4, and T5. There were no significant differences, 
except for a lower mixed venous oxygen saturation (SVO2) after 
weaning from CPB in the ISO group. Although there was no 
difference in mean SVO2 at 1 hour after ICU admission, two 
patients, both from the ISO group, had a critically low Sv02 of 
<50%. The Pa02 /FIO2 ratio, which was comparable in both 
groups after induction of anesthesia, showed a strong decrease 
after CPB and postoperatively in either group, although the 
decrease tended to be greater in the ISO group (Table 5). 
Although the individual differences were not statistically signifi­
cant, they were consistent at the three postoperative time points. 
Also, Qs/Qt, determined at 1 hour after ICU admission, tended 
to be lower in the ISO group (p = 0.055).
Time to awakening and to tracheal extubation, and the 
amount of fentanyl and midazolam administered in the time 
between ICU admission and extubation, were not significantly 
different between the two groups (Table 5). Discharge from ICU 
was also comparable in both groups. Only one patient, from the 
MID group, had an ICU stay of more than 4 nights because of a 
gram-negative sepsis.
DISCUSSION
This study shows that both MID and ISO, as adjuncts to 
moderate-dose fentanyl (up to 50 jug/kg), generally produced 
satisfactory perioperative hemodynamic conditions during elec­
tive CABG. They did not, however, prevent all hypertensive
Table 4. Blood Gas and Oxygenation Data
Group T, t 3 t 4 Ts
pHa MID 7.38 (0.04) 7.36 (0.03) 7.35 (0.05) 7.42 (0.05)
ISO 7.42 (0.04) 7.39 (0.04) 7.36 (0.07) 7.41 (0.05)
PaC02 (mmHg) MID 35 (4) 38 (4) 39 (4) 34 (4)
ISO 33 (4) 36 (4) 38 (7) 35 (5)
Pa02 (mmHg) MID 216(47) 218 (47) 153(52) 176 (61)
ISO 212(41) 236 (50) 123 (58) 144(47)
Sv02 (%) MID 79 (6) 77 (8) 78 (7)* 71 (4)
ISO 77 (6) 80(6) 70 (5)* 70(10)
HCO3 (mEq/L) MID 21.3(1.4) 21.4(1.6) 21.2 (1.8) 22.0 (2.0)
ISO 21.5(1.3) 21.7(1.5) 21.2 (2.1) 21.9(1.8)
Hemoglobin g/dL MID 12.4(1.5) 7.7 (0.8) 8.6 (0.8) 10.7 (0.8)
ISO 12.3(1.7) 7.9 (0.8) 8.3 (0.9) 10.4(1.1)
NOTE. Data represent mean and SD.
Abbreviations: Sv02, mixed venous or venous (during CPB) oxygen saturation; T1; before skin incision; T3, 10 minutes after release of the aortic 
cross-clamp; T4/10 minutes after the end of CPB;TS, 1 hour after ICU admission.
*p < 0.05 for differences between ISO and MID groups.
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Table 5. Early Postoperative Patient Data
Group MID Group ISO
Time to awaking (min) 217(73) 193 (96)
Time to extubation (h) 19.5 (1.5) 18.2 (3.6)
Fentanyl in ICU (mg) 0.89 (0.4) 0.98 (0.4)
Midazolam in ICU (mg) 36.5(11.5) 36.2 (11.2)
ICU stay
<48 hours 11 11
48-72 hours 2 3
72-95 hours 1 1
>96 hours 1 0
Hospital stay (days) 10.0 (3.4) 8.9 (2.6)
Pa02/F102
1 hour Anesthesia 432 (94) 430(105)
1 hour ICU 300 (115) 259 (82)
10 hour ICU 317(126) 266 (77)
18 hour ICU 297(122) 230 (81)
Qs/Qt {%)
1 hour Anesthesia 11.6(4.5) 10.6 (3.3)
1 hour ICU 13.9 (6.3) 18.6 (6.8)*
NOTE. Values between brackets represent SD of mean. 
*p = 0.055 for differences between MID and ISO groups
episodes, and both can lead to episodes of hypotension. The 
overall difference between them was that, in the doses investi­
gated, a significantly higher frequency and dose of antihyperten­
sive escape medication during the pre-CPB period were re­
quired in the MJD-supplemented group than in the ISO group. 
In contrast, ISO had to be stopped more frequently in the 
post-CPB period because of hypotension..
ISO was selected as the volatile agent of choice. Despite 
controversy about possible “ coronary steal," ISO, as an adjunct 
to opioids, has been shown to produce stable hemodynamics 
during cardiac surgery with no greater risk of myocardial 
ischemia compared with pure high-dose opioid anesthesia.7,8 
These authors used even higher concentrations of isoflurane 
than in this study. In a comparative study between haJothane 
and isoflurane (0.5 MAC inspiratory concentration) as adjuncts 
lo 50 |jg/kg of fentanyl and not as the primary anesthetic, there 
was no difference in regional coronary flow and metabolism and 
in the incidence of myocardial ischemic episodes during 
CABG, even in patients with so-called steal-prone coronary 
anatomy.1* The current study groups were too small lo conclude 
about myocardial ischemia, but the comparably low incidence 
of new ST-segment deviations and the lack of difference in 
postoperative creatine kinase-myocardial bound (CK-MB) iso­
enzyme in the MID and ISO groups confirm the data of the 
aforementioned studies that a 0.5 MAC concentration of 
isoflurane does not cause coronary steal when systemic hemody­
namics are maintained.
The favorable hemodynamic effects of MID reported in 
patients with coronary artery disease5-10' 12 have been confirmed 
in a recent study of Messina et al,u in which a bolus of 0.1 
mg/kg of MID was given between induction and incision. MID 
did not affect cardiac index in the entire study population 
despite a decrease in systolic function. The apparent myocardial 
depression was offset by a similar decrease in aiterload. Even in
high-risk patients with reduced preoperative ejection fraction, 
the mild adverse effects of MID were not greater. The MID 
dosing in this study (0.05 to 0.1 mg/kg/h) was higher than 
reported by Theil et al,M who found that MID infusion rates 
between 0.025 and 0.04 mg/kg/hour as adjunct to fentanyl (30 
to 35 pg/kg total dose) provided excellent hemodynamic 
stability in CABG patients with opioid drug concentrations 
lower than techniques based on fentanyl alone. However, they 
used much higher intraoperative doses of vasodilators and 
allowed the use of (3-blockers and inhalation agents to treat 
hypertension.
This study could not show a difference in postoperative 
awakening, sedative and analgesic requirements, extubation, 
and ICU discharge between the MID and ISO groups. The 
figures for extubation and ICU discharge agree with those 
summarized from the literature by Mora et al4 for several 
different anesthetic techniques for myocardial revasculariza­
tion, This shows that nonanesthetic factors largely determine 
the timing of extubation and that only high-dose opioid 
anesthesia techniques require prolonged ventilatory support 
compared with balanced techniques. This study, although not 
primarily intended to favor early extubation, showed no differ­
ence in postoperative duration of sedative-hypnotic effects 
between ISO or MID, and equal amounts of sedative-analgesic 
maintenance medication were required. The use of MID supple­
mentation in the setting of early extubation needs to be further 
investigated to determine its optimal dosing regimen.
Greater impairment in oxygenation after CPB was found in 
the ISO group than in the MID group. Cardiac surgery is 
frequently followed by impaired oxygen exchange, which is du^ : 
not only to increased extravascular lung water, but also to 
atelectasis in dependent lung areas.15 The difference between 
MID and ISO might be explained by the inhibition of hypoxic 
pulmonary vasoconstriction induced by ISO and a subsequently 
greater pulmonary shunt.16 The P a 0 2/FI02 ratio used in this 
study is a simple and reliable measure of the extent of 
pulmonary shunt and impairment of oxygenation when the 
range of F I0 2s is small (between 0.4 and 0.6).17 It remains, 
however, difficult to explain why this difference in shunt 
between the ISO and MID groups persisted for several hours 
after the end of anesthesia.
This study confirms previous observations that the choice of 
prebypass anesthetic does not affect cardiac outcome, but that 
agents used to supplement opioids such as the volatile agents 
and the benzodiazepines can prevent hypertension. They can, 
however, also lead to hypotensive episodes.i8*21 The route of 
administration and the careful titration of the drug dose with the 
effect may be more important in “ balanced anesthesia’’ for 
heart surgery than the drugs themselves.3
In conclusion, this study shows that both MID, 0.05 to 0.1 
mg/kg/h, and ISO, 0.5 MAC, are adequate adjuncts to moderate 
doses of fentanyl to control perioperative hemodynamics during 
CABG. Further study of the optimal dose regimen of MID with 
respect to early extubation techniques» and of the possible 
effects of ISO on the postoperative impairment of oxygenation 
in CABG, is warranted.
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